ORIGINAL RESEARCH
Accepted on 19 Mar 2025
Identification of Dinaciclib and Ganetespib as Anti-inflammatory Drugs Using a Novel HTP Screening Assay that Targets IFNγ-dependent PD-L1 Expression
doi 10.3389/fimmu.2025.1502094
- Frontiers in Immunology
- Immunological Tolerance and Regulation
- Research Topics
- Immune Tolerance Strategies: How has Immunotherapy of Cancer Informed Novel Approaches?
Immune Tolerance Strategies: How has Immunotherapy of Cancer Informed Novel Approaches?
580
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.